期刊文献+

银屑病患者生活质量调查 被引量:45

The investigation of life quality in patients with psoriasis
下载PDF
导出
摘要 目的:研究银屑病对患者生活质量的影响及皮肤病生活质量指数(DLQI)作为判断银屑病病情及疗效新指标的可信性。方法:采用DLQI研究银屑病患者治疗前、后的生活质量及其影响因素,并与传统的银屑病皮损面积和严重度指数(PASI)进行比较。结果:女性患者的DLQI评分明显高于男性,未婚者的DLQI评分高于已婚者,面部受累者的DLQI评分高于面部未受累者(P<0.05)。DLQI和PASI评分呈显著正相关(r=0.633,P<0.001)。治疗后随着临床病情的改善,PASI和DLQI评分均显著下降,且DLQI改善率和PASI改善率呈显著正相关(r=0.722,P<0.001)。结论:银屑病对患者生活质量的影响较大,DLQI可作为判断银屑病病情及疗效的新指标。 Objective: To study the effect of psoriasis on the patients life quality and to evaluate the reliability of dermatology life quality index(DLQI) as a new severity and therapeutic index of psoriasis. Methods: Compared with psoriasis area and severity index (PASI), DLQI was used to evaluate the life quality in the patients with psoriasis before and after treatment and its affecting factors. Results: The DLQI scores were significantly higher in females than those in males. The scores were also significantly higher in the singlehood patients or the face-involved patients than those in married or the patients with no face lesion respectively (P〈0.05). There was a significantly positive correlation between PASI and DLQI scores (r=0.633,P〈 0.001). Both PASI and DLQI decreased with clinical improvement after treatment. There was also a significantly positive correlation of the response rate between in PASI and DLQI scores (r= 0.722, P〈 0.001). Conclusion: Psoriasis has marked effect on patients life quality and DLQI score can be a new severity and therapeutic index of psoriasis.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2006年第6期370-372,共3页 Journal of Clinical Dermatology
关键词 银屑病 皮肤病生活质量指数 银屑病皮损面积和严重度指数 psoriasis dermatology life quality index psoriasis area and severity index
  • 相关文献

参考文献7

  • 1Krueger G,Koo J,Lebwohl M,et al.The impact of psoriasis on quality of lifer results of a 1998 National Psoriasis Foundation patient-membership survey[J].Arch Dermatol,2001,137(3):280-284.
  • 2Mazzotti E,Picardi A,Sampogna F,et al.Sensitivity of the Dermatology Life Quality Index to clinical change in patients with psoriasis[J].Br J Dermatol,2003,149(2):318-322.
  • 3党宁宁.不同皮肤病生活质量的比较研究[J].中国皮肤性病学杂志,2004,18(4):221-222. 被引量:30
  • 4Zaghloul SS,Goodfield MJ.Objective assessment of compliance with psoriasis treatment[J].Arch Dermatol,2004,140(4):408-414.
  • 5Feldman SR,Menter A,Koo JY.Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis[J].Br J Dermatol,2004,150(2):317-326.
  • 6Menter A,Kosinski M,Bresnahan BW,et al.Impact of efalizumab on psoriasis-specific patient-reported outcomes.Results from three randomized,placebo-controlled clinical trials of moderate to severe plaque psorlasis[J].J Drugs Dermatol,2004,3(1):27-38.
  • 7Feldman SR,Gordon KB,Bala M,et al.Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis:a double -blind placebo-controlled trial[J].Br J Dermatol,2005,152(5):954-960.

二级参考文献4

  • 1Finaly AY,Khan GK.Dermatology life quality index(DLQI)-a simple practical measure for routine clinical use[J].Clin Exp Dermatol,1994,19:210-216.
  • 2Linn HD.Results of a quality of life questionnaire in a patch test clinic population[J].Contact Dermatitis,2001,44:80-84.
  • 3Finaly AY,Kelly SE.Psoriasis-an index of disability[J].Clin Exp Dermatol,1987,12:8-11.
  • 4Motley RJ,Finlay AY.How much disability is caused by acne[J].Clin Exp Dermatol,1989,14:194-198.

共引文献29

同被引文献349

引证文献45

二级引证文献307

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部